A 12-week consultation on draft proposals outlining a new Cancer Drugs Fund (CDF) has been launched. The aim of the new CDF is to help patients receive new treatments with genuine promise, while real world evidence is collected for up to two years on how well they work in practice. This will then help determine […]
The Cancer Drugs Fund (CDF) has today completed a further review of the effectiveness of treatments it funds to ensure it delivers the best outcomes for patients. Professor Peter Clark, Chair of the Cancer Drugs Fund and an oncologist, said: “There is no escaping the fact that we face a difficult set of choices, but […]
One of the world’s leading cancer doctors says avoiding disease is key to lowering healthcare costs – with patient education and data the untapped NHS tools of prevention. Dr David Agus, who is Professor of Medicine and Engineering at the University of Southern California as well as a New York Times bestselling author and CBS news contributor, […]
The 100,000 Genomes Project has taken another major step forward with a move to recruit cancer patients. The Oxford NHS Genomic Medicine Centre – one of 11 such centres in the country launched as part of the 100,000 Genomes Project last December – is the first in the country open to recruit patients with cancer […]
Taskforce report aims to boost cancer survival and transform patient experience Six strategic priorities have today (Sunday) been recommended by the Independent Cancer Taskforce to help the NHS achieve world-class cancer outcomes. The cancer report outlines how an additional 30,000 patients every year could survive cancer for 10 years or more by 2020. Of these, around […]
The first centres to treat patients with stereotactic ablative radiotherapy (SABR), as part of NHS England’s latest national evaluation programme, will be able to start accepting patients from today (Monday). NHS England has invested £15m over three years to assess the use of SABR through its Commissioning through Evaluation initiative, which will allow up to […]
NHS England has published an updated Cancer Drugs Fund (CDF) list following decisions, made by cancer doctors and patient representatives at the last national CDF panel meeting, that aim to deliver the maximum clinical benefit for patients. The updated CDF list reflects the outcomes of the appeals from pharmaceutical companies following the removal of drugs […]
NHS England’s Medical Director, Professor Sir Bruce Keogh, has welcomed the announcement of the equipment and building suppliers which will start work on the UK’s first proton beam therapy cancer centres this summer. The Government is investing £250 million in the building of the two specialist centres at University College London Hospitals NHS Foundation Trust […]
The NHS Cancer Drugs Fund (CDF) today (Monday) published the outcome of its review of drugs included in the Fund. The budget for the CDF will grow from £200 million in 2013/14, to £280 million in 2014/15, and an estimated £340 million from April 2015. This represents a total increase of 70 per cent since […]
NHS England today (Sunday) announced a new independent taskforce to develop a five-year action plan for cancer services that will improve survival rates and save thousands of lives. It also launched a major new programme to test innovative ways of diagnosing cancer more quickly at more than 60 sites across the country, and committed a further £15m over three years to evaluate and treat patients with a type of modern […]